Update on the Complications and Management of Liver Cirrhosis
Medical Sciences · 05.02.2025 · 13 (1) · 13
DOI: 10.3390/medsci13010013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 05.02.2025. Verfasst von Hiba Fadlallah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon. Hauptthemen laut MEDLINE: Liver Cirrhosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liver cirrhosis represents the advanced pathological stage of chronic liver disease, characterized by the progressive destruction and regeneration of the hepatic parenchyma over years, culminating in fibrosis and disruption of the vascular architecture. As a leading global cause of morbidity and mortality, it continues to affect millions worldwide, imposing a substantial burden on healthcare systems. Alcoholic/nonalcoholic fatty liver disease and chronic viral hepatitis infection, hepatitis C (HCV) in particular, remain leading causes of cirrhosis. Despite significant advances in understanding the pathogenesis of cirrhosis, its management is still complex due to the multifaceted complications, including ascites, hepatic encephalopathy, variceal bleeding, and hepatocellular carcinoma, all of which severely compromise the patient outcomes and quality of life. This review aims at filling a critical gap by providing a comprehensive summary of the latest evidence on the complications and management of liver cirrhosis. Evidence-based therapies targeting both the etiologies and complications of cirrhosis are essential for improving outcomes. While liver transplantation is considered a definitive cure, advancements in pharmacological therapies offer promising avenues for halting and potentially reversing disease progression. This review summarizes the latest management strategies for cirrhosis and its associated complications, emphasizing the importance of early intervention and novel therapeutic options for improving outcomes and quality of life in affected individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon.
- Faculty of Medicine, University of Balamand, Al-Kurah, Tripoli P.O. Box 100, Lebanon.
- Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Faculty of Medical Sciences, Lebanese University, Beirut 1107-2020, Lebanon.
ORCID-Profile: Hisham F Bahmad, Wassim Abou-Kheir
Zitieren
APA
Fadlallah, H., El Masri, D., Bahmad, H. F., Abou-Kheir, W., & El Masri, J. (2025). Update on the Complications and Management of Liver Cirrhosis. Medical Sciences, 13(1), 13. https://doi.org/10.3390/medsci13010013
Vancouver
Fadlallah H, El Masri D, Bahmad HF, Abou-Kheir W, El Masri J. Update on the Complications and Management of Liver Cirrhosis. Medical Sciences. 2025;13(1):13. doi:10.3390/medsci13010013
BibTeX
@article{Fadlallah2025,
author = {Fadlallah, Hiba and El Masri, Diala and Bahmad, Hisham F and Abou-Kheir, Wassim and El Masri, Jad},
title = {Update on the Complications and Management of Liver Cirrhosis},
journal = {Medical Sciences},
year = {2025},
volume = {13},
number = {1},
pages = {13},
doi = {10.3390/medsci13010013}
}
EUVIMED